We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Accrol Group Holdings Plc | LSE:ACRL | London | Ordinary Share | GB00BZ6VT592 | ORD GBP0.001 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.25 | -0.65% | 38.20 | 38.00 | 38.40 | 38.50 | 38.20 | 38.20 | 3,036,351 | 16:29:27 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Convrt Paper,paperbd Pds,nec | 241.91M | -5.7M | -0.0179 | -21.34 | 121.81M |
TIDMACRL
Accrol Group Holdings PLC
15 December 2020
RNS Reach
15 December 2020
ACCROL GROUP HOLDINGS PLC
("Accrol" or the "Group")
AIM: ACRL
ONLINE INVESTOR PRESENTATION
Accrol Group, one of the UK's leading independent tissue converters, is pleased to announce that following the successful acquisition of Leicester Tissue Company ("LTC") in November 2020, the Group's CEO senior management team is hosting a presentation to provide retail investors with background on Accrol, the Board's strategy and ambitions and the rationale for the acquisition of LTC.
The webinar will take place at 2.00pm today, 15 December 2020, via Zoom.
If you would like to join the webinar, please email georgina@melloevents.com, who will provide login details.
Hot Features
Premium
For further information, please contact:
Accrol Group Holdings plc
Dan Wright, Executive Chairman Via Belvedere Communications
Gareth Jenkins, Chief Executive Officer
Zeus Capital Limited (Nominated Adviser
& Broker)
Dan Bate / Jordan Warburton Tel: +44 (0) 161 831 1512
Dominic King / John Goold Tel: +44 (0) 203 829 5000
Liberum Capital Limited (Joint Broker) Tel: +44 (0) 20 3100 2222
Clayton Bush / Edward Thomas
Belvedere Communications Limited
Cat Valentine Tel: +44 (0) 7715 769 078
Keeley Clarke Tel: +44 (0) 7967 816 525
Llew Angus Tel: +44 (0) 7407 023 147
accrolpr@belvederepr.com
Overview of Accrol
Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls and facial tissues to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisition of a state-of-the-art tissue converter based in Leicester, the Group now operates from five sites, including four in Lancashire, which generate revenues totalling c.16% of the GBP1.7bn UK retail tissue market.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRABIBDDIDBDGGS
(END) Dow Jones Newswires
December 15, 2020 02:00 ET (07:00 GMT)
1 Year Accrol Chart |
1 Month Accrol Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
